HYPERAMMONIUM IN PATIENTS WITH PRECIRRHOSIS STAGE: CLINICAL REALITY?
Ammonia belongs to the common neuro- and cytotoxic metabolites in the human. It is established that ammonia has hepatotoxic properties. Ammonia induces the formation of oxygen active forms, reduces the activity of endothelial NO synthase, dose-dependently decreases the cellular metabolism and prolif...
Saved in:
| Main Authors: | L. Yu. Ilchenko, I. G. Nikitin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
SINAPS LLC
2018-06-01
|
| Series: | Архивъ внутренней медицины |
| Subjects: | |
| Online Access: | https://www.medarhive.ru/jour/article/view/786 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EXPERIENCE OF ORNITHINE ASPARTATE (HEPA-MERZ) AND PROBIOTICS BIOFLORUM FORTE IN THE TREATMENT OF NON-SEVERE FORMS OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE
by: L. Yu. Ilchenko, et al.
Published: (2016-10-01) -
Results of using L-ornitin-L-aspartate in the treatment of hepatic encephalopathy in liver transplantation
by: S. E. Voskanyan, et al.
Published: (2021-09-01) -
Efficacy and safety of L-ornithine L-aspartate combined with lactulose in treatment of hepatic encephalopathy: a systematic review and meta-analysis of randomized controlled trial
by: Hui Zhang, et al.
Published: (2025-04-01) -
L-Ornithine-L-Aspartate and Intermittent Renal Replacement Therapy in Fulminant Hepatitis A
by: Nourhane Obeid, et al.
Published: (2023-03-01) -
Diagnostic and Prognostic Value of Hyperammonemia in Patients with Liver Cirrhosis, Hepatic Encephalopathy, and Sarcopenia (Experts’ Agreement)
by: M. Yu. Nadinskaia, et al.
Published: (2024-03-01)